Global Veterinary Infectious Diseases Therapeutics Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Veterinary Infectious Diseases Therapeutics Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Antibiotics
  • 1.2.3 Antiviral
  • 1.2.4 Antifungal
  • 1.2.5 Amebicides
  • 1.2.6 Anthelmintics
• 1.3 Market by Application
  • 1.3.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Swine
  • 1.3.3 Chicken
  • 1.3.4 Dog
  • 1.3.5 Cat
  • 1.3.6 Cow
  • 1.3.7 Horse
  • 1.3.8 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Veterinary Infectious Diseases Therapeutics Sales Estimates and Forecasts 2017-2028
• 2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Veterinary Infectious Diseases Therapeutics Sales by Region
  • 2.4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2022)
  • 2.4.2 Global Sales Veterinary Infectious Diseases Therapeutics by Region (2023-2028)
• 2.5 Global Veterinary Infectious Diseases Therapeutics Revenue by Region
  • 2.5.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2022)
  • 2.5.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers
  • 3.1.1 Global Top Veterinary Infectious Diseases Therapeutics Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Infectious Diseases Therapeutics in 2021
• 3.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers
  • 3.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Veterinary Infectious Diseases Therapeutics Revenue in 2021
• 3.3 Global Veterinary Infectious Diseases Therapeutics Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Veterinary Infectious Diseases Therapeutics Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Type
  • 4.1.1 Global Veterinary Infectious Diseases Therapeutics Historical Sales by Type (2017-2022)
  • 4.1.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
• 4.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Type
  • 4.2.1 Global Veterinary Infectious Diseases Therapeutics Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
• 4.3 Global Veterinary Infectious Diseases Therapeutics Price by Type
  • 4.3.1 Global Veterinary Infectious Diseases Therapeutics Price by Type (2017-2022)
  • 4.3.2 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Veterinary Infectious Diseases Therapeutics Sales by Application
  • 5.1.1 Global Veterinary Infectious Diseases Therapeutics Historical Sales by Application (2017-2022)
  • 5.1.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
• 5.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Application
  • 5.2.1 Global Veterinary Infectious Diseases Therapeutics Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
• 5.3 Global Veterinary Infectious Diseases Therapeutics Price by Application
  • 5.3.1 Global Veterinary Infectious Diseases Therapeutics Price by Application (2017-2022)
  • 5.3.2 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Veterinary Infectious Diseases Therapeutics Market Size by Type
  • 6.1.1 North America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
  • 6.1.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
• 6.2 North America Veterinary Infectious Diseases Therapeutics Market Size by Application
  • 6.2.1 North America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
  • 6.2.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
• 6.3 North America Veterinary Infectious Diseases Therapeutics Market Size by Country
  • 6.3.1 North America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
  • 6.3.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Veterinary Infectious Diseases Therapeutics Market Size by Type
  • 7.1.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
  • 7.1.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
• 7.2 Europe Veterinary Infectious Diseases Therapeutics Market Size by Application
  • 7.2.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
  • 7.2.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
• 7.3 Europe Veterinary Infectious Diseases Therapeutics Market Size by Country
  • 7.3.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
  • 7.3.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Size by Type
  • 8.1.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
• 8.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Size by Application
  • 8.2.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
• 8.3 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Size by Region
  • 8.3.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Veterinary Infectious Diseases Therapeutics Market Size by Type
  • 9.1.1 Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
  • 9.1.2 Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
• 9.2 Latin America Veterinary Infectious Diseases Therapeutics Market Size by Application
  • 9.2.1 Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
  • 9.2.2 Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
• 9.3 Latin America Veterinary Infectious Diseases Therapeutics Market Size by Country
  • 9.3.1 Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
  • 9.3.2 Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Size by Type
  • 10.1.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Size by Application
  • 10.2.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Size by Country
  • 10.3.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Elanco Animal Health
  • 11.1.1 Elanco Animal Health Corporation Information
  • 11.1.2 Elanco Animal Health Overview
  • 11.1.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Elanco Animal Health Recent Developments
• 11.2 Novartis Animal Health
  • 11.2.1 Novartis Animal Health Corporation Information
  • 11.2.2 Novartis Animal Health Overview
  • 11.2.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Novartis Animal Health Recent Developments
• 11.3 Merck
  • 11.3.1 Merck Corporation Information
  • 11.3.2 Merck Overview
  • 11.3.3 Merck Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Merck Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Merck Recent Developments
• 11.4 Pfizer Animal Health
  • 11.4.1 Pfizer Animal Health Corporation Information
  • 11.4.2 Pfizer Animal Health Overview
  • 11.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Pfizer Animal Health Recent Developments
• 11.5 Sanofi
  • 11.5.1 Sanofi Corporation Information
  • 11.5.2 Sanofi Overview
  • 11.5.3 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Sanofi Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Sanofi Recent Developments
• 11.6 Boehringer Ingelheim Vetmedica
  • 11.6.1 Boehringer Ingelheim Vetmedica Corporation Information
  • 11.6.2 Boehringer Ingelheim Vetmedica Overview
  • 11.6.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Boehringer Ingelheim Vetmedica Recent Developments
• 11.7 Dechra Animal Health
  • 11.7.1 Dechra Animal Health Corporation Information
  • 11.7.2 Dechra Animal Health Overview
  • 11.7.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Dechra Animal Health Recent Developments
• 11.8 Ceva Sante Animale
  • 11.8.1 Ceva Sante Animale Corporation Information
  • 11.8.2 Ceva Sante Animale Overview
  • 11.8.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Ceva Sante Animale Recent Developments
• 11.9 Elanco Animal Health
  • 11.9.1 Elanco Animal Health Corporation Information
  • 11.9.2 Elanco Animal Health Overview
  • 11.9.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Elanco Animal Health Recent Developments
• 11.10 Virbac
  • 11.10.1 Virbac Corporation Information
  • 11.10.2 Virbac Overview
  • 11.10.3 Virbac Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Virbac Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Virbac Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Veterinary Infectious Diseases Therapeutics Industry Chain Analysis
• 12.2 Veterinary Infectious Diseases Therapeutics Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Veterinary Infectious Diseases Therapeutics Production Mode & Process
• 12.4 Veterinary Infectious Diseases Therapeutics Sales and Marketing
  • 12.4.1 Veterinary Infectious Diseases Therapeutics Sales Channels
  • 12.4.2 Veterinary Infectious Diseases Therapeutics Distributors
• 12.5 Veterinary Infectious Diseases Therapeutics Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Veterinary Infectious Diseases Therapeutics Industry Trends
• 13.2 Veterinary Infectious Diseases Therapeutics Market Drivers
• 13.3 Veterinary Infectious Diseases Therapeutics Market Challenges
• 13.4 Veterinary Infectious Diseases Therapeutics Market Restraints

14 Key Findings in The Global Veterinary Infectious Diseases Therapeutics Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Antibiotics
• Table 3. Major Manufacturers of Antiviral
• Table 4. Major Manufacturers of Antifungal
• Table 5. Major Manufacturers of Amebicides
• Table 6. Major Manufacturers of Anthelmintics
• Table 7. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 8. Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 9. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2022) & (KG)
• Table 10. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2017-2022)
• Table 11. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2023-2028) & (KG)
• Table 12. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2023-2028)
• Table 13. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2022) & (US$ Million)
• Table 14. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2017-2022)
• Table 15. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2023-2028) & (US$ Million)
• Table 16. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2023-2028)
• Table 17. Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers (2017-2022) & (KG)
• Table 18. Global Veterinary Infectious Diseases Therapeutics Sales Share by Manufacturers (2017-2022)
• Table 19. Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 20. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Manufacturers (2017-2022)
• Table 21. Veterinary Infectious Diseases Therapeutics Price by Manufacturers (2017-2022) &(USD/KG)
• Table 22. Global Veterinary Infectious Diseases Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 23. Global Veterinary Infectious Diseases Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Infectious Diseases Therapeutics as of 2021)
• Table 24. Veterinary Infectious Diseases Therapeutics Manufacturing Base Distribution and Headquarters
• Table 25. Manufacturers Veterinary Infectious Diseases Therapeutics Product Offered
• Table 26. Date of Manufacturers Enter into Veterinary Infectious Diseases Therapeutics Market
• Table 27. Mergers & Acquisitions, Expansion Plans
• Table 28. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
• Table 29. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
• Table 30. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2017-2022)
• Table 31. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2023-2028)
• Table 32. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
• Table 33. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
• Table 34. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2017-2022)
• Table 35. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2023-2028)
• Table 36. Veterinary Infectious Diseases Therapeutics Price by Type (2017-2022) & (USD/KG)
• Table 37. Global Veterinary Infectious Diseases Therapeutics Price Forecast by Type (2023-2028) & (USD/KG)
• Table 38. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
• Table 39. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
• Table 40. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2017-2022)
• Table 41. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2023-2028)
• Table 42. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
• Table 43. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
• Table 44. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2017-2022)
• Table 45. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2023-2028)
• Table 46. Veterinary Infectious Diseases Therapeutics Price by Application (2017-2022) & (USD/KG)
• Table 47. Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2023-2028) & (USD/KG)
• Table 48. North America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
• Table 49. North America Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
• Table 50. North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
• Table 51. North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
• Table 52. North America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
• Table 53. North America Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
• Table 54. North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
• Table 55. North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
• Table 56. North America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
• Table 57. North America Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
• Table 58. North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
• Table 59. North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
• Table 60. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
• Table 61. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
• Table 62. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
• Table 63. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
• Table 64. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
• Table 65. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
• Table 66. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
• Table 67. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
• Table 68. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
• Table 69. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
• Table 70. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
• Table 71. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
• Table 72. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
• Table 73. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
• Table 74. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
• Table 75. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
• Table 76. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
• Table 77. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
• Table 78. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
• Table 79. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
• Table 80. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2022) & (KG)
• Table 81. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2023-2028) & (KG)
• Table 82. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2022) & (US$ Million)
• Table 83. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2023-2028) & (US$ Million)
• Table 84. Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
• Table 85. Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
• Table 86. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
• Table 87. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
• Table 88. Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
• Table 89. Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
• Table 90. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
• Table 91. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
• Table 92. Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
• Table 93. Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
• Table 94. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
• Table 95. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
• Table 96. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
• Table 97. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
• Table 98. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
• Table 99. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
• Table 100. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
• Table 101. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
• Table 102. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
• Table 103. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
• Table 104. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
• Table 105. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
• Table 106. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
• Table 107. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
• Table 108. Elanco Animal Health Corporation Information
• Table 109. Elanco Animal Health Description and Major Businesses
• Table 110. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
• Table 111. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
• Table 112. Elanco Animal Health Recent Developments
• Table 113. Novartis Animal Health Corporation Information
• Table 114. Novartis Animal Health Description and Major Businesses
• Table 115. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
• Table 116. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
• Table 117. Novartis Animal Health Recent Developments
• Table 118. Merck Corporation Information
• Table 119. Merck Description and Major Businesses
• Table 120. Merck Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
• Table 121. Merck Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
• Table 122. Merck Recent Developments
• Table 123. Pfizer Animal Health Corporation Information
• Table 124. Pfizer Animal Health Description and Major Businesses
• Table 125. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
• Table 126. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
• Table 127. Pfizer Animal Health Recent Developments
• Table 128. Sanofi Corporation Information
• Table 129. Sanofi Description and Major Businesses
• Table 130. Sanofi Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
• Table 131. Sanofi Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
• Table 132. Sanofi Recent Developments
• Table 133. Boehringer Ingelheim Vetmedica Corporation Information
• Table 134. Boehringer Ingelheim Vetmedica Description and Major Businesses
• Table 135. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
• Table 136. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
• Table 137. Boehringer Ingelheim Vetmedica Recent Developments
• Table 138. Dechra Animal Health Corporation Information
• Table 139. Dechra Animal Health Description and Major Businesses
• Table 140. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
• Table 141. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
• Table 142. Dechra Animal Health Recent Developments
• Table 143. Ceva Sante Animale Corporation Information
• Table 144. Ceva Sante Animale Description and Major Businesses
• Table 145. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
• Table 146. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
• Table 147. Ceva Sante Animale Recent Developments
• Table 148. Elanco Animal Health Corporation Information
• Table 149. Elanco Animal Health Description and Major Businesses
• Table 150. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
• Table 151. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
• Table 152. Elanco Animal Health Recent Developments
• Table 153. Virbac Corporation Information
• Table 154. Virbac Description and Major Businesses
• Table 155. Virbac Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
• Table 156. Virbac Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
• Table 157. Virbac Recent Developments
• Table 158. Key Raw Materials Lists
• Table 159. Raw Materials Key Suppliers Lists
• Table 160. Veterinary Infectious Diseases Therapeutics Distributors List
• Table 161. Veterinary Infectious Diseases Therapeutics Customers List
• Table 162. Veterinary Infectious Diseases Therapeutics Market Trends
• Table 163. Veterinary Infectious Diseases Therapeutics Market Drivers
• Table 164. Veterinary Infectious Diseases Therapeutics Market Challenges
• Table 165. Veterinary Infectious Diseases Therapeutics Market Restraints
• Table 166. Research Programs/Design for This Report
• Table 167. Key Data Information from Secondary Sources
• Table 168. Key Data Information from Primary Sources

List of Figures

• Figure 1. Veterinary Infectious Diseases Therapeutics Product Picture
• Figure 3. Global Veterinary Infectious Diseases Therapeutics Market Share by Type in 2021 & 2028
• Figure 3. Antibiotics Product Picture
• Figure 4. Antiviral Product Picture
• Figure 5. Antifungal Product Picture
• Figure 6. Amebicides Product Picture
• Figure 7. Anthelmintics Product Picture
• Figure 8. Global Veterinary Infectious Diseases Therapeutics Market Share by Application in 2021 & 2028
• Figure 9. Swine
• Figure 10. Chicken
• Figure 11. Dog
• Figure 12. Cat
• Figure 13. Cow
• Figure 14. Horse
• Figure 15. Other
• Figure 16. Veterinary Infectious Diseases Therapeutics Report Years Considered
• Figure 17. Global Veterinary Infectious Diseases Therapeutics Sales 2017-2028 (KG)
• Figure 18. Global Veterinary Infectious Diseases Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 19. Global Veterinary Infectious Diseases Therapeutics Revenue 2017-2028 (US$ Million)
• Figure 20. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 21. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2017-2022)
• Figure 22. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2023-2028)
• Figure 23. North America Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
• Figure 24. North America Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
• Figure 25. Europe Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
• Figure 26. Europe Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
• Figure 27. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
• Figure 28. Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
• Figure 29. Latin America Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
• Figure 30. Latin America Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
• Figure 31. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
• Figure 32. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
• Figure 33. The Veterinary Infectious Diseases Therapeutics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 34. The Top 5 and 10 Largest Manufacturers of Veterinary Infectious Diseases Therapeutics in the World: Market Share by Veterinary Infectious Diseases Therapeutics Revenue in 2021
• Figure 35. Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 36. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
• Figure 37. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
• Figure 38. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
• Figure 39. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
• Figure 40. North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
• Figure 41. North America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
• Figure 42. North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
• Figure 43. North America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
• Figure 44. North America Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
• Figure 45. North America Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
• Figure 46. U.S. Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 47. Canada Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 48. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
• Figure 49. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
• Figure 50. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
• Figure 51. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
• Figure 52. Europe Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
• Figure 53. Europe Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
• Figure 54. Germany Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 55. France Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 56. U.K. Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 57. Italy Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 58. Russia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 59. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
• Figure 60. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
• Figure 61. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
• Figure 62. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
• Figure 63. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Share by Region (2017-2028)
• Figure 64. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Share by Region (2017-2028)
• Figure 65. China Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 66. Japan Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 67. South Korea Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 68. India Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 69. Australia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 70. Taiwan Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 71. Indonesia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 72. Thailand Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 73. Malaysia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 74. Philippines Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 75. Latin America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
• Figure 76. Latin America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
• Figure 77. Latin America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
• Figure 78. Latin America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
• Figure 79. Latin America Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
• Figure 80. Latin America Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
• Figure 81. Mexico Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 82. Brazil Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 83. Argentina Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 84. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
• Figure 85. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
• Figure 86. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
• Figure 87. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
• Figure 88. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
• Figure 89. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
• Figure 90. Turkey Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 91. Saudi Arabia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 92. U.A.E Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
• Figure 93. Veterinary Infectious Diseases Therapeutics Value Chain
• Figure 94. Veterinary Infectious Diseases Therapeutics Production Process
• Figure 95. Channels of Distribution
• Figure 96. Distributors Profiles
• Figure 97. Bottom-up and Top-down Approaches for This Report
• Figure 98. Data Triangulation
• Figure 99. Key Executives Interviewed